Lv33
308 积分 2025-07-25 加入
A modular framework for antibody–drug conjugate biomarkers
1天前
待确认
Antibody–drug conjugates: a practical review on clinical management of toxicities
1天前
已完结
Risk of Ophthalmotoxicity Associated with Antibody-Drug Conjugates: A Systematic Review and Meta-analysis
1天前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review
1天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
1天前
已完结
Exploring the immunological effects of antibody–drug conjugates
1天前
已完结
Antibody–drug conjugates in gynaecological cancers: opportunities and challenges
1天前
已完结
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
2个月前
已完结
Overall Survival with Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLC
3个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
4个月前
已完结